Pharmacist HIV/PrEP/PEP | Infectious Disease | Patient Safety Podcast 30 credit minutes

Recent developments in HIV prevention — including the FDA approval of a 6-month injectable option and updated clinical guidance — are changing the landscape of Pre-Exposure Prophylaxis (PrEP) therapy. This course reviews the latest developments, compares prevention strategies, and examines how these changes affect PrEP delivery, counseling, and monitoring. You will gain timely insights to better counsel patients, support adherence, and contribute to prevention strategies in your practice.

Learning Objectives

Upon successful completion of this course, pharmacists should be able to:
1. Describe key new HIV PrEP therapy options recently approved or recommended, including their dosing schedules and clinical indications.
2. Identify pharmacist responsibilities when counseling patients about PrEP, including initiation, adherence, monitoring, and risk-benefit discussions. 

Faculty

Rachel Maynard, PharmD

GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

Disclosures:

Rachel Maynard has no relevant financial relationships with ineligible companies to disclose.

David Hachey, PharmD, AAHIVP

Professor
Idaho State University 

Disclosures:

David Hachey has no relevant financial relationships with ineligible companies to disclose.

Course Details